Cargando…
Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota
Qinglong Zhidong Decoction (QLZDD), a traditional Chinese medicine (TCM) prescription, has been effectively used to alleviate Tourette syndrome (TS) in children. However, the therapeutic mechanism of QLZDD on TS has not been evaluated. The present study aims to elucidate the therapeutic effect and t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981146/ https://www.ncbi.nlm.nih.gov/pubmed/35392572 http://dx.doi.org/10.3389/fphar.2022.819872 |
_version_ | 1784681540989485056 |
---|---|
author | Wang, Na Wu, Xinchen Yang, Qi Wang, Dingyue Wu, Zhao Wei, Yuanyuan Cui, Jieqiong Hong, Li Xiong, Lei Qin, Dongdong |
author_facet | Wang, Na Wu, Xinchen Yang, Qi Wang, Dingyue Wu, Zhao Wei, Yuanyuan Cui, Jieqiong Hong, Li Xiong, Lei Qin, Dongdong |
author_sort | Wang, Na |
collection | PubMed |
description | Qinglong Zhidong Decoction (QLZDD), a traditional Chinese medicine (TCM) prescription, has been effectively used to alleviate Tourette syndrome (TS) in children. However, the therapeutic mechanism of QLZDD on TS has not been evaluated. The present study aims to elucidate the therapeutic effect and the possible therapeutic mechanism of QLZDD on TS in mouse model. A 3,3-iminodipropionitrile (IDPN, 350 mg/kg)-induced-TS mouse model was established. The mice were randomly divided into the control group, the model group, the haloperidol group (14 mg/kg), the low-, middle-, or high-QLZDD-dose groups (6.83 g/kg, 13.65 g/kg, 27.3 g/kg). QLZDD was administrated orally once a day for 4 weeks. The tic-like behavior was recorded weekly. Then, neurotransmitters and neurotransmitter receptors were analyzed by ELISA, immunohistochemistry (IHC), and quantitative reverse transcription PCR in striatum. Further, the alteration to intestinal flora was monitored by 16s rRNA sequencing, and the role of gut microbiota in the alleviation of TS by QLZDD was investigated. QLZDD ameliorated the tic-like behavior, and decreased the level of excitatory neurotransmitters such as Glu and DA and increased the level of the inhibitory neurotransmitter GABA significantly. Moreover, QLZDD significantly blocked the mRNA expression and the protein expression of D1R and D2R in the striatum, while activated the levels of DAT and GABAR. Interestingly, QLZDD mediated the composition of gut microbiota by increasing the abundance of Lactobacillus and Bacteroides but decreasing the abundance of Alloprevotella and Akkermansia. Taken together, QLZDD ameliorated the tic-like behavior in TS mouse, its mechanism of action may be associated with restoring the balance of gut microbiota and neurotransmitters. The study indicated a promising role of QLZDD in alleviating TS and a therapeutic strategy for fighting TS in clinical settings. |
format | Online Article Text |
id | pubmed-8981146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89811462022-04-06 Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota Wang, Na Wu, Xinchen Yang, Qi Wang, Dingyue Wu, Zhao Wei, Yuanyuan Cui, Jieqiong Hong, Li Xiong, Lei Qin, Dongdong Front Pharmacol Pharmacology Qinglong Zhidong Decoction (QLZDD), a traditional Chinese medicine (TCM) prescription, has been effectively used to alleviate Tourette syndrome (TS) in children. However, the therapeutic mechanism of QLZDD on TS has not been evaluated. The present study aims to elucidate the therapeutic effect and the possible therapeutic mechanism of QLZDD on TS in mouse model. A 3,3-iminodipropionitrile (IDPN, 350 mg/kg)-induced-TS mouse model was established. The mice were randomly divided into the control group, the model group, the haloperidol group (14 mg/kg), the low-, middle-, or high-QLZDD-dose groups (6.83 g/kg, 13.65 g/kg, 27.3 g/kg). QLZDD was administrated orally once a day for 4 weeks. The tic-like behavior was recorded weekly. Then, neurotransmitters and neurotransmitter receptors were analyzed by ELISA, immunohistochemistry (IHC), and quantitative reverse transcription PCR in striatum. Further, the alteration to intestinal flora was monitored by 16s rRNA sequencing, and the role of gut microbiota in the alleviation of TS by QLZDD was investigated. QLZDD ameliorated the tic-like behavior, and decreased the level of excitatory neurotransmitters such as Glu and DA and increased the level of the inhibitory neurotransmitter GABA significantly. Moreover, QLZDD significantly blocked the mRNA expression and the protein expression of D1R and D2R in the striatum, while activated the levels of DAT and GABAR. Interestingly, QLZDD mediated the composition of gut microbiota by increasing the abundance of Lactobacillus and Bacteroides but decreasing the abundance of Alloprevotella and Akkermansia. Taken together, QLZDD ameliorated the tic-like behavior in TS mouse, its mechanism of action may be associated with restoring the balance of gut microbiota and neurotransmitters. The study indicated a promising role of QLZDD in alleviating TS and a therapeutic strategy for fighting TS in clinical settings. Frontiers Media S.A. 2022-03-22 /pmc/articles/PMC8981146/ /pubmed/35392572 http://dx.doi.org/10.3389/fphar.2022.819872 Text en Copyright © 2022 Wang, Wu, Yang, Wang, Wu, Wei, Cui, Hong, Xiong and Qin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Wang, Na Wu, Xinchen Yang, Qi Wang, Dingyue Wu, Zhao Wei, Yuanyuan Cui, Jieqiong Hong, Li Xiong, Lei Qin, Dongdong Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota |
title | Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota |
title_full | Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota |
title_fullStr | Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota |
title_full_unstemmed | Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota |
title_short | Qinglong Zhidong Decoction Alleviated Tourette Syndrome in Mice via Modulating the Level of Neurotransmitters and the Composition of Gut Microbiota |
title_sort | qinglong zhidong decoction alleviated tourette syndrome in mice via modulating the level of neurotransmitters and the composition of gut microbiota |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981146/ https://www.ncbi.nlm.nih.gov/pubmed/35392572 http://dx.doi.org/10.3389/fphar.2022.819872 |
work_keys_str_mv | AT wangna qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota AT wuxinchen qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota AT yangqi qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota AT wangdingyue qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota AT wuzhao qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota AT weiyuanyuan qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota AT cuijieqiong qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota AT hongli qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota AT xionglei qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota AT qindongdong qinglongzhidongdecoctionalleviatedtourettesyndromeinmiceviamodulatingthelevelofneurotransmittersandthecompositionofgutmicrobiota |